Aspect Partners »

Agios Pharmaceuticals shares owned by Aspect Partners

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Aspect Partners from 13F filings

Historical chart of Aspect Partners investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Aspect Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Aspect Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.0k 361 22.27

More positions owned by Aspect Partners

Spdr S&p 500 Etf Trust Etf (SPY)
Ishares U.s. Real Estate Etf Etf (IYR)
Ishares Msci Eafe Etf Etf (EFA)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares Core International Aggregate Bond Etf Etf (IAGG)
Real Estate Select Sector Spdr Fund Etf (XLRE)
Invesco Optimum Yield Diversified Commodity Strategy No K-1 Etf Etf (PDBC)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Core S&p Small Cap Etf Etf (IJR)
Vanguard International Dividend Appreciation Etf Etf (VIGI)
Spdr Gold Shares Etf (GLD)
Alpha Architect 1-3 Month Box Etf Etf (BOXX)
Vaneck Gold Miners Etf Etf (GDX)

View all positions for Aspect Partners

Top funds holding Agios Pharmaceuticals

Vanguard Group
Bellevue Group
Dimensional Fund Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Arrowpoint Asset Management
Citadel Advisors
Bnp Paribas Investment Partners
Fisher Investments
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Frazier Life Sciences Management
Hudson Bay Capital Management
Charles Schwab Investment Management
Assenagon Asset Management

View all funds holding Agios Pharmaceuticals